Literature DB >> 19040556

Ang II and Ang IV: unraveling the mechanism of action on synaptic plasticity, memory, and epilepsy.

Dimitri De Bundel1, Ilse Smolders, Patrick Vanderheyden, Yvette Michotte.   

Abstract

The central angiotensin system plays a crucial role in cardiovascular regulation. More recently, angiotensin peptides have been implicated in stress, anxiety, depression, cognition, and epilepsy. Angiotensin II (Ang II) exerts its actions through AT(1) and AT(2) receptors, while most actions of its metabolite Ang IV were believed to be independent of AT(1) or AT(2) receptor activation. A specific binding site with high affinity for Ang IV was discovered and denominated "AT(4) receptor". The beneficiary effects of AT(4) ligands in animal models for cognitive impairment and epileptic seizures initiated the search for their mechanism of action. This proved to be a challenging task, and after 20 years of research, the nature of the "AT(4) receptor" remains controversial. Insulin-regulated aminopeptidase (IRAP) was first identified as the high-affinity binding site for AT(4) ligands. Recently, the hepatocyte growth factor receptor c-MET was also proposed as a receptor for AT(4) ligands. The present review focuses on the effects of Ang II and Ang IV on synaptic transmission and plasticity, learning, memory, and epileptic seizure activity. Possible interactions of Ang IV with the classical AT(1) and AT(2) receptor subtypes are evaluated, and other potential mechanisms by which AT(4) ligands may exert their effects are discussed. Identification of these mechanisms may provide a valuable target in the development in novel drugs for the treatment of cognitive disorders and epilepsy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19040556      PMCID: PMC6494056          DOI: 10.1111/j.1755-5949.2008.00057.x

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  18 in total

Review 1.  The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases.

Authors:  John W Wright; Joseph W Harding
Journal:  Pflugers Arch       Date:  2012-04-26       Impact factor: 3.657

Review 2.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 3.  Effects of angiotensin-II on brain endothelial cell permeability via PPARalpha regulation of para- and trans-cellular pathways.

Authors:  Shuzhen Guo; Angel T Som; Ken Arai; Eng H Lo
Journal:  Brain Res       Date:  2019-07-26       Impact factor: 3.252

4.  Central administration of angiotensin IV rapidly enhances novel object recognition among mice.

Authors:  Jason J Paris; Shainnel O Eans; Elisa Mizrachi; Kate J Reilley; Michelle L Ganno; Jay P McLaughlin
Journal:  Neuropharmacology       Date:  2013-02-14       Impact factor: 5.250

5.  Long non-coding RNA and mRNA analysis of Ang II-induced neuronal dysfunction.

Authors:  Lin-Lin Shao; Yue-Hua Jiang; Ling-Yu Jiang; Chuan-Hua Yang; Ying-Zi Qi
Journal:  Mol Biol Rep       Date:  2019-04-03       Impact factor: 2.316

6.  AGTR1 gene variation: association with depression and frontotemporal morphology.

Authors:  Warren D Taylor; Sophiya Benjamin; Douglas R McQuoid; Martha E Payne; Ranga R Krishnan; James R MacFall; Allison Ashley-Koch
Journal:  Psychiatry Res       Date:  2012-06-15       Impact factor: 3.222

7.  Brain Renin-Angiotensin System Blockade Attenuates Methamphetamine-Induced Hyperlocomotion and Neurotoxicity.

Authors:  Linhong Jiang; Ruiming Zhu; Qian Bu; Yan Li; Xue Shao; Hui Gu; Jueying Kong; Li Luo; Hailei Long; Wei Guo; Jingwei Tian; Yinglan Zhao; Xiaobo Cen
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

8.  Facilitation of hippocampal synaptogenesis and spatial memory by C-terminal truncated Nle1-angiotensin IV analogs.

Authors:  Caroline C Benoist; John W Wright; Mingyan Zhu; Suzanne M Appleyard; Gary A Wayman; Joseph W Harding
Journal:  J Pharmacol Exp Ther       Date:  2011-06-30       Impact factor: 4.030

Review 9.  The Potential Therapeutic Capacity of Inhibiting the Brain Renin-Angiotensin System in the Treatment of Co-Morbid Conditions in Epilepsy.

Authors:  Natasha Ivanova; Jana Tchekalarova
Journal:  CNS Drugs       Date:  2019-11       Impact factor: 5.749

10.  Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents.

Authors:  Alene T McCoy; Caroline C Benoist; John W Wright; Leen H Kawas; Jyote M Bule-Ghogare; Mingyan Zhu; Suzanne M Appleyard; Gary A Wayman; Joseph W Harding
Journal:  J Pharmacol Exp Ther       Date:  2012-10-10       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.